#United States #New York #Securities Law #Charming Medical #MCTA

Charming Medical Limited Faces Class Action Lawsuit

Charming Medical Limited, a company listed on NASDAQ under the ticker MCTA, is currently embroiled in a class action lawsuit. Initiated by the DJS Law Group, this legal action highlights serious allegations regarding violations of the Securities Exchange Act of 1934, specifically §§10(b) and 20(a), along with SEC Rule 10b-5. The litigation aims to hold the company accountable for allegedly making false and misleading statements that impacted shareholders significantly.

Details of the Allegations

The lawsuit centers on claims that Charming Medical provided inaccurate information to the market, which resulted in inflated stock prices. According to the complaint filed by the DJS Law Group, the company was involved in an elaborate scheme where supposed financial advisors promoted its shares on social media in an attempt to artificially boost the stock price. This resulted in the temporary suspension of trading for Charming's shares by the U.S. Securities and Exchange Commission (SEC), signaling serious concerns regarding the company's financial communications.

Class Period and Important Dates

For investors interested in joining the case, it’s essential to note the class period spans from October 21, 2025, to November 12, 2025. The deadline for potential plaintiffs to join the lawsuit is set for February 17, 2026. Those who purchased shares of MCTA during this period are particularly encouraged to reach out to DJS Law Group to explore their options for pursuing recovery. It is important to clarify that involvement as a lead plaintiff is not obligatory for participation in the lawsuit.

Impact on Shareholders

The fallout of these allegations has raised questions among current and former shareholders concerning the integrity of Charming Medical's reporting practices. As the company faces scrutiny, it becomes critical for investors who experienced losses during the alleged class period to consider their legal rights and options. DJS Law Group stresses the importance of collective action in such scenarios, advocating for the rights and recoveries of affected investors.

DJS Law Group's Role

DJS Law Group specializes in securities class actions and has a solid reputation for navigating complex corporate governance litigation. Their focus lies in maximizing investor returns through balanced legal strategies and vigorous advocacy. According to their representatives, the firm has been representing some of the world's most discerning hedge funds and alternative asset managers, making them well-equipped to tackle the nuances of this case.

Investors who have experienced a decline in the value of their shares as a result of the firm’s actions are urged to participate in the lawsuit. By coming together, investors can strengthen their chances of recovery while holding companies accountable for misleading practices.

How to Get Involved

If you are a shareholder who suffered financial losses due to your investment in Charming Medical shares during the specified period, it is recommended that you contact the DJS Law Group. They can guide you on the necessary steps to join the class action and potentially recover your losses. Remember to act swiftly, as the opportunities for legal recourse are time-sensitive.

For more information or to discuss your case, contact David J. Schwartz at DJS Law Group via phone or email. Take charge of your rights as an investor and consider the options available to you under this class action lawsuit. It is essential to remain informed and proactive in protecting your investment interests.